Click here for more information or to register for the symposia.

CyberKnife System Symposium: Sunday, September 24th from 12:15p.m. PT - 1:15p.m. PT


Clinical Experience with Breast Applications
Jonathan Haas, MD, Winthrop University Hospital, United States
Prostate SBRT – Heterogeneous Dose Distribution: Rationale, Methods, Outcomes and Future Direction: 2017 Update
Donald B. Fuller, MD, Genesis Healthcare Partners, United States
Head and Neck Skull Base Stereotactic Radiotherapy Plan Comparison Study: Gamma Knife, CyberKnife®, Linac Photons, or Protons?
Jack Phan, MD, PhD, MD Anderson Cancer Center, United States
Radixact™ System Symposium: Monday, September 25th from 12:30p.m. PT - 1:30 p.m. PT

TomoTherapy versus RapidArc: Comparison of Clinical Outcomes in Head & Neck Cancers
Jean-Emmanuel Bibault, MD, MSc, Georges Pompidou European Hospital, France
Adaptive Replanning and Delivery Verification with PreciseART on Radixact
X. Allen Li, PhD, DABMP, FAAPM, Medical College of Wisconsin, United States
UW Radixact Experience
John Bayouth, PhD, University of Wisconsin – Madison School of Medicine and Public Health, United States
AERO™ Academy Sessions: September 24th – September 26th

Presentations will be hosted on a daily basis at Accuray booth #1517. Attendees will have the opportunity to engage in interactive discussions on the real-world use of Accuray technologies with clinical experts. Topics include CyberKnife prostate SBRT, using the TomoTherapy System for whole breast irradiation and the feasibility of real-time motion management with the Radixact System.

About Accuray

Accuray Incorporated (NASDAQ: ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments.

SOURCE Accuray Incorporated

Back to HCB News

CT Homepage